Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of Naoxintong preparation in preparation of medicine for treating non-alcoholic fatty liver disease

A non-alcoholic, brain-heart-passing technology, used in drug combinations, pharmaceutical formulations, plant raw materials, etc., can solve problems such as clinical application limitations, the impact of patients' quality of life and life expectancy, liver and kidney damage, etc., to expand the scope of medicinal use , the effect of improving liver function indicators

Pending Publication Date: 2022-03-04
SUN YAT SEN UNIV
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At the same time, the pathogenesis of NAFLD is complex, and there are multiple pathogenic factors, which have a serious impact on the quality of life and life expectancy of patients.
[0003] At present, modern medicine mostly uses exercise and weight loss as the main treatment for NAFLD. Chemical drugs, such as lipid-lowering and blood-sugar-lowering drugs, need to be taken for a long time, and are prone to adverse reactions such as liver and kidney damage, and their clinical application is limited.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of Naoxintong preparation in preparation of medicine for treating non-alcoholic fatty liver disease
  • Application of Naoxintong preparation in preparation of medicine for treating non-alcoholic fatty liver disease
  • Application of Naoxintong preparation in preparation of medicine for treating non-alcoholic fatty liver disease

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0024] Embodiment 1 in vivo animal model experiment

[0025] 1. Experimental materials

[0026] 1.1 Test drug: Naoxintong Capsules (NXT)

[0027] 1.2 Control drug: atorvastatin (ATO)

[0028] 1.3 High-fat feed: containing 21% fat and 1.5% cholesterol

[0029] 2. Experimental animals

[0030] APOE - / - 45 mice, SPF grade, male, weighing 20-25g, 15 C57BL / 6J mice, SPF grade, male, weighing 20-25g, experimental animal quality certificate number: SCXK (Guangdong) 2018-0002 issued by Guangdong Province Provided by the Animal Center for Medical Experiments.

[0031] 3. Experimental method

[0032] The present invention adopts APOE - / - The non-alcoholic fatty liver animal model was established by feeding mice with high-fat diet for 24 weeks, and its curative effect was verified by intragastric administration of Naoxintong capsules.

[0033] High-fat diet-induced fatty liver is recognized as one of the classic models of NAFLD, and rodents fed a high-fat diet for a long time will...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a new medicinal application of a Naoxintong preparation, and particularly relates to an application of the Naoxintong preparation in preparation of a medicine for treating non-alcoholic fatty liver. Experiments prove that the Naoxintong preparation can significantly reduce the body weight, liver weight / body weight index and liver lipid deposition of non-alcoholic fatty liver model animals, significantly improve liver function indexes including aspartate transaminase (AST) and glutamic-pyruvic transaminase (ALT), significantly reduce the levels of triglyceride (TG), cholesterol (TC) and low density lipoprotein (LDL-C) in serum in vivo, and significantly improve the liver function indexes of non-alcoholic fatty liver model animals. The traditional Chinese medicine composition has a remarkable effect on treating the non-alcoholic fatty liver disease. The medicinal range of the Naoxintong preparation is further expanded.

Description

technical field [0001] The invention relates to a new medicine application of Naoxintong preparation, especially the application in preparing medicine for treating non-alcoholic fatty liver. Background technique [0002] Non-alcoholic fatty liver disease (Non-alcoholic Fatty Liver Disease, NAFLD) refers to the clinical chronic liver disease caused by excluding alcohol and other liver damage factors, with excessive fat deposition in liver cells as the key pathological feature, including simple fatty liver , nonalcoholic steatohepatitis, liver fibrosis, cirrhosis, and hepatocellular carcinoma. At present, with the increase in the obesity rate of the global population, the global incidence of NAFLD is as high as 18-30%, and the risk of complications such as cardiovascular and cerebrovascular diseases and type 2 diabetes is increasing year by year, which seriously threatens human health. At the same time, the pathogenesis of NAFLD is complex and there are multiple pathogenic fa...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/736A61P1/16A61P3/06A61P3/04A61K35/62A61K35/646
CPCA61K36/481A61K36/71A61K36/65A61K36/537A61K36/232A61K36/236A61K36/736A61K36/286A61K36/324A61K36/328A61K36/486A61K36/21A61K36/54A61K36/605A61K35/62A61K35/646A61P1/16A61P3/06A61P3/04A61K2300/00
Inventor 吴灏张伟健苏薇薇王永刚姚宏亮
Owner SUN YAT SEN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products